C R Divgi
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- HER2/EGFR in Cancer Research
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 6
- Radiopharmaceutical Chemistry and Applications 6
- Medical Imaging Techniques and Applications 1
- Oncology 6
- Peptidase Inhibition and Analysis 3
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Steven M. Larson (3 shared papers)Ronald D. Finn (3 shared papers)S Welt (3 shared papers)E A Carswell (2 shared papers)Andrew M. Scott (3 shared papers)Lloyd J. Old (2 shared papers)Alfred Cohen (1 shared paper)Martin C. Graham (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Molecular Imaging and Biology (1 paper)Seminars in Nuclear Medicine (1 paper)International Journal of Oncology (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesNetherlandsAustralia
In The Last Decade
C R Divgi
11 papers receiving 570 citations
Peers
Comparison fields: 5 of 54
- Oncology 307
- Radiology, Nuclear Medicine and Imaging 247
- Cancer Research 114
- Pulmonary and Respiratory Medicine 150
- Biotechnology 28
Countries citing papers authored by C R Divgi
This map shows the geographic impact of C R Divgi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C R Divgi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C R Divgi more than expected).
Fields of papers citing papers by C R Divgi
This network shows the impact of papers produced by C R Divgi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C R Divgi. The network helps show where C R Divgi may publish in the future.
Co-authors
The 25 scholars most cited alongside C R Divgi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 205 | |
| 2 | 1993 | 141 | |
| 3 | 1989 | 81 | |
| 4 | 2007 | 25 | |
| 5 | 1989 | 24 | |
| 6 | Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer. | 1996 | 23 |
| 7 | Novel investigative approaches for advanced renal cell carcinoma. | 2000 | 22 |
| 8 | 1998 | 21 | |
| 9 | Pilot radioimmunotherapy trial with 131I-labeled murine monoclonal antibody CC49 and deoxyspergualin in metastatic colon carcinoma. | 1995 | 19 |
| 10 | 2015 | 18 | |
| 11 | 2006 | 2 |
About C R Divgi
C R Divgi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 11 papers that have together received 581 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Peptidase Inhibition and Analysis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Pancreatic function and diabetes (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Diabetes Management and Research (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Oncology (307 citations), Radiology, Nuclear Medicine and Imaging (247 citations), Cancer Research (114 citations), Pulmonary and Respiratory Medicine (150 citations) and Biotechnology (28 citations). C R Divgi has collaborated with scholars based in United States, Netherlands and Australia. Frequent co-authors include Steven M. Larson, Ronald D. Finn, S Welt, E A Carswell, Andrew M. Scott, Lloyd J. Old, Alfred Cohen, Martin C. Graham, Pilar Garin‐Chesa and S. O. Warnaar. Their work appears in journals such as Journal of Clinical Oncology, Molecular Imaging and Biology, Seminars in Nuclear Medicine, International Journal of Oncology and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.